07:49 AM EDT, 05/15/2024 (MT Newswires) -- Perspective Therapeutics ( CATX ) reported a Q1 loss Wednesday of $0.02 per diluted share, compared with breakeven a year earlier.

Five analysts polled by Capital IQ expected a loss of $0.03.

Revenue for the quarter ended March 31 was $325,000, compared with $233,000 a year earlier.

Five analysts surveyed by Capital IQ expected $70,000.

Price: 1.8000, Change: +0.04, Percent Change: +2.27